Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results
Date:12/12/2011

ad cash, cash equivalents and investments in securities totaling $81.8 million, including cash and cash equivalents of $79.5 million and restricted investments in securities of $2.3 million.

Note to Investors: As previously announced, Avanir will hold a conference call to discuss fiscal 2011 full year financial results today, December 12, 2011, beginning at 1:30 p.m. Pacific Time. You can listen to this call by dialing 1-877-558-3407 for domestic callers or +1-706-679-1941 for international callers, and entering passcode 33791527. Those interested in listening to the conference call live via the internet may do so by visiting http://www.avanir.com.

About AVP-923AVP-923 is a combination of two well-characterized compounds: the active ingredient dextromethorphan hydrobromide (an uncompetitive NMDA receptor antagonist and sigma-1 receptor agonist) and low dose quinidine sulfate (a CYP2D6 enzyme inhibitor), which serves to increase the bioavailability of dextromethorphan. The dosage form of AVP-923 of 20 mg DM/10 mg Q capsules (twice daily) is approved by the FDA under the brand name NUEDEXTA® which is indicated for the treatment of pseudobulbar affect (PBA).

About NUEDEXTANUEDEXTA® is the first and only FDA-approved treatment for pseudobulbar affect (PBA). NUEDEXTA is an innovative combination of two well-characterized components; dextromethorphan hydrobromide (20 mg), the ingredient active in the central nervous system, and quinidine sulfate (10 mg), a metabolic inhibitor enabling therapeutic dextromethorphan concentrations. NUEDEXTA acts on sigma-1 and NMDA receptors in the brain, although the mechanism by which NUEDEXTA exerts therapeutic effects in patients with PBA is unknown.

NUEDEXTA is not approved for the treatment of central neuropathic pain.

NUEDEXTA Important Safety InformationNUEDEXTA can interact with other medications causing significant changes in blood lev
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
2. Avanir Pharmaceuticals to Participate in Piper Jaffray Health Care Conference
3. Avanir Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for NUEDEXTA
4. Avanir Pharmaceuticals Submits European Marketing Authorization Application for NUEDEXTA
5. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
6. Avanir Pharmaceuticals to Participate in Two Investor Conferences
7. Avanir Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
8. Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
9. Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results
10. Avanir Pharmaceuticals Announces Appointment of Dr. Joao Siffert as Senior Vice President Research and Development
11. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... -- Bayer HealthCare announced today that it has contributed ... the American Society of Clinical Oncology (ASCO) to support ... to unlock vast quantities of information about the experiences ... is proud to join ASCO and the Conquer Cancer ... help people whose lives have been affected by cancer," ...
(Date:3/5/2015)... 5, 2015  Medical Diagnostic Laboratories, L.L.C., (MDL), ... complexity, state-of-the-art, automated DNA-based molecular analyses, announces that ... testing which utilizes cutting edge technology, including next- ... approximately 12,000 women are diagnosed with cervical cancer ... Genital Human Papillomaviruses (HPV) are a group of ...
(Date:3/5/2015)... LAWRENCEVILLE, N.J. , March 5, 2015 /PRNewswire/ ... today that the Company will host a conference ... provide an update on its development programs for ... and two newly acquired technology platforms, TheraPlas™ and ... a.m. ET on Thursday, March 12, 2015. To ...
Breaking Medicine Technology:Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2
(Date:3/5/2015)... Testosterone lawsuits ( http://www.testosteronelawsuithub.com/ ) filed ... strokes and other serious cardiovascular events due to their ... forward in the federal multidistrict litigation now underway in ... a Case Management Order issued on March 3rd, the ... master pleadings in the proceeding. Among other things, the ...
(Date:3/5/2015)... 05, 2015 HomeCEUConnection.com is ... with extra savings on their nutrition CEUs. ... health and nutrition, HomeCEUConnection.com is offering 10% ... promo code, NUTRITION2015 . , High ... , HomeCEUConnection.com provides high-quality continuing education courses ...
(Date:3/5/2015)... 2015 SuperCloset has released a new video ... aims to teach viewers everything they need to know about ... a SuperPro takes you from seed all the way through ... to how to prune Grow Like a SuperPro will help ... whole series for download for a special introductory price of ...
(Date:3/5/2015)... 2015 At the 7th Annual ... in addiction treatment met today in Jackson, Mississippi to ... practices. Among the numerous respected speakers will be ... the role that pain medications have had in today’s ... options. , "It is hard to believe that much ...
(Date:3/5/2015)... Calif. (PRWEB) March 05, 2015 ... the leader in the natural products coffee drinks category[1], ... Natural Products Expo West in Anaheim, Calif. Concentrated ... café concept, Califia Café, which democratizes the next wave ... the ingredients they need to become their own baristas. ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4
... Researchers from the Harvard School of Public Health (HSPH) ... growing momentum for //indoor smoking bans in countries across ... smoking ban as a likely tipping point for fundamental ... ,Since 2004, in only a few years, more than ...
... of Otolaryngology – Head and Neck Surgery is offering a ... pollen in the air, and how an ear, nose, and ... blooming trees and plants will join other allergens in affecting ... nasal congestion and drainage, and sometimes headache. This year, some ...
... pressured hospital system would struggle to cope under a ... large-scale emergency, say trauma and emergency specialists.// ... for Australasian hospitals, says Dr Anthony Joseph, Director of ... ,In the latest Medical Journal of Australia (MJA), ...
... TB is scary because it can also spread to humans, ... human cases in England,// out of which one ended in ... the need for better controls and checks to be instituted. ... HPA using DNA finger printing, it was seen that all ...
... World' fact is truly becoming stranger than fiction. ... // human sperms from a source far removed ... human bone marrow are now the new ‘fathers’ of immature ... to benefit infertile men. ,The pioneering scientists from the ...
... to All India Institute of Medical Sciences (AIIMS) Director ... by a former patient alleging// that the state-run hospital ... patients undergoing treatment at its cardiac and neuro center. ... Thursday to Venugopal, Mayank Sharma, former senior financial advisor, ...
Cached Medicine News:Health News:Global Momentum for Smoke-Free Indoor Environments at Tipping Point 2Health News:April Showers Bring May Flowers – And Plenty of Pollen, To 2Health News:Can Our Hospitals Cope In A Disaster? 2Health News:Breakthrough Discovery- Human Sperms From Bone Marrow 2Health News:Court Issues Notice to Venugopal Over Fund Irregularities 2
... a vital dye, used in matured cataract ... fibrous tissue enables the surgeon to see ... preparation of trypan blue combined with sodium ... tolerated following intraocular injection into the anterior ...
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Refkeratometer...
Portable, easy to align, automatic measurement, automatic fogging. Accurate and dependable readings. Infrared printer communication. Rechargeable battery. Integrates with the TRS-2100 and EPIC-2100 r...
Medicine Products: